P. Hanjani
All authors
About
Publications While At HealthPartners
selected publications
Journal Article
Quality of life and adverse events: prognostic relationships in long-term ovarian cancer survival
.
Journal of the National Cancer Institute.
2021
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
.
Annals of Oncology.
2017
Contact
full name
P.
Hanjani
Quick Info
Collaboration
Co-author network
Map of science